Similar articles for PMID: 23787910

Year	Number of Results
2011	3
2012	5
2013	13
2014	9
2015	7
2016	10
2017	16
2018	13
2019	15
2020	5
2021	4
2022	3
2023	2
2024	0

1

Galectin-3 and new-onset CKD: marker or mediator?

Ravani P, Barrett BJ. Ravani P, et al. J Am Soc Nephrol. 2013 Sep;24(9):1342-4. doi: 10.1681/ASN.2013050552. Epub 2013 Jun 20. J Am Soc Nephrol. 2013. PMID: 23787910 Free PMC article. No abstract available.

2

Elevated galectin-3 precedes the development of CKD.

O'Seaghdha CM, Hwang SJ, Ho JE, Vasan RS, Levy D, Fox CS. O'Seaghdha CM, et al. J Am Soc Nephrol. 2013 Sep;24(9):1470-7. doi: 10.1681/ASN.2012090909. Epub 2013 Jun 13. J Am Soc Nephrol. 2013. PMID: 23766533 Free PMC article.

3

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J. Rebholz CM, et al. Kidney Int. 2018 Jan;93(1):252-259. doi: 10.1016/j.kint.2017.06.028. Epub 2017 Aug 31. Kidney Int. 2018. PMID: 28865675 Free PMC article.

4

Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease.

Savic J, Zeljkovic A, Bogavac-Stanojevic N, Simic-Ogrizovic S, Kravljaca M, Stosovic M, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Gojkovic T, Spasic S. Savic J, et al. Scand J Clin Lab Invest. 2014 Oct;74(7):637-43. doi: 10.3109/00365513.2014.928944. Epub 2014 Jun 24. Scand J Clin Lab Invest. 2014. PMID: 24958359

5

High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.

Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW. Chan GC, et al. Int Urol Nephrol. 2020 Mar;52(3):533-540. doi: 10.1007/s11255-020-02390-5. Epub 2020 Feb 1. Int Urol Nephrol. 2020. PMID: 32008204

6

GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.

Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N. Tuegel C, et al. Am J Kidney Dis. 2018 Oct;72(4):519-528. doi: 10.1053/j.ajkd.2018.03.025. Epub 2018 Jun 14. Am J Kidney Dis. 2018. PMID: 29866459 Free PMC article.

7

Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.

Ji F, Zhang S, Jiang X, Xu Y, Chen Z, Fan Y, Wang W. Ji F, et al. J Clin Lab Anal. 2017 Sep;31(5):e22074. doi: 10.1002/jcla.22074. Epub 2016 Oct 11. J Clin Lab Anal. 2017. PMID: 27726176 Free PMC article.

8

Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis.

Zhang T, Cao S, Yang H, Li J. Zhang T, et al. Int Urol Nephrol. 2019 Jun;51(6):1005-1011. doi: 10.1007/s11255-019-02123-3. Epub 2019 Apr 8. Int Urol Nephrol. 2019. PMID: 30963453

9

Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.

Mueller T, Leitner I, Egger M, Haltmayer M, Dieplinger B. Mueller T, et al. Clin Chim Acta. 2015 May 20;445:155-60. doi: 10.1016/j.cca.2015.03.033. Epub 2015 Apr 4. Clin Chim Acta. 2015. PMID: 25850080 Free article.

10

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.

Drechsler C, Delgado G, Wanner C, Blouin K, Pilz S, Tomaschitz A, Kleber ME, Dressel A, Willmes C, Krane V, Krämer BK, März W, Ritz E, van Gilst WH, van der Harst P, de Boer RA. Drechsler C, et al. J Am Soc Nephrol. 2015 Sep;26(9):2213-21. doi: 10.1681/ASN.2014010093. Epub 2015 Jan 7. J Am Soc Nephrol. 2015. PMID: 25568176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year